ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2007

Generation of Human Induced Pluripotent Stem Cell Lines from Patients with Hand Osteoarthritis

Rocío Castro-Viñuelas1, Clara Sanjurjo-Rodríguez2, María Piñeiro-Ramil2, Tamara Hermida-Gómez3, Francisco Javier De Toro Santos4, Francisco J Blanco5, Isaac Fuentes-Boquete2 and Silvia María Díaz-Prado2, 1Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., A Coruña, Spain, 2Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., A CORUÑA, Spain, 3Grupo de Bioingeniería Tisular y Terapia Celular (CBTTC-CHUAC). CIBER-BBN/ISCIII. Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de Coruña (CHUAC). SERGAS. Universidade de A Coruña, A Coruña, Spain, 4Cell Therapy and Regenerative Medicine research group. Dept. Physiotherapy, Medicine and Biomedical Sciences. University of A Coruña. Institute of Biomedical Research of A Coruña (INIBIC), A Coruña, Spain., La Coruña, Spain, 5Grupo de Investigación en Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cell therapy, iPS (induced pluripotent stem cells) and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Although hand osteoarthritis (OA) is a worldwide burden, there is no treatment able to cure it. Induced pluripotent stem cells (iPSCs) are considered ideal sources for exploring cell therapies and they have emerged as promising tools for modelling diseases. The advantages of using iPSC lines are unlimited cell source and chondrogenic differentiation potential. However, there are no studies generating iPSCs from patients with hand OA. Therefore, the aim of this study has been to generate iPSC-lines from patients with hand OA and healthy donors, which can be useful for studying the pathogenesis of the disease in vitro and for testing new drugs.

Methods: Patients with hand OA (rhizarthrosis) and a healthy control were selected for the study. Fibroblasts from 3mm skin biopsies of these patients were isolated. The transcriptional factors Oct4, Sox2, Klf4 and c-Myc were used for the reprogramming process; which was performed by using the non-integrating method Sendai virus (Fig 1A). Cell lines obtained were morphological, phenotypical and functionally characterized. Furthermore, to evaluate weather these iPSC lines could be used as cellular model of hand OA, presence of single nucleotide polymorphisms (SNPs) within the gene encoding the retinaldehyde dehydrogenase 2 (ALDH1A2) was studied by Sanger sequencing, before and after reprogramming. The variant rs3204689 within the ALDH1A2 gene has been associated with severe OA of the hand (OR=1.46, p=1.1 x 10-11) (Styrkarsdottir et al., 2014).

Results: Fibroblasts were isolated from skin biopsies of two patients with radiographic hand OA and one healthy donor, which presented a normal karyotype: 46,XX. Three weeks after reprogramming, embryonic stem cell-like colonies emerged in culture (Fig 1B). These cells showed positivity for alkaline phosphatase activity (Fig 1B) and the pluripotency markers Tra1-81 and Nanog (Fig 1D). Molecular analyses showed high relative expression levels of the pluripotency-related genes OCT4, SOX2, NANOG and CRIPTO in the iPSCs (Fig 1C). These cells were also able to give rise to cells from the three germ layers. Indeed, during mesodermal differentiation, spontaneously beating cardiomyocytes were seen in culture. Regarding SNPs studies, cells from one of the patients with hand OA were homozygous for the at-risk C allele, both before and after reprogramming. Cells obtained from the healthy donor and the second OA hand patient were heterozygous for this variant (Fig 1E).

Conclusion: The reprogramming process using Sendai virus enabled us to generate iPSC lines from patients with hand OA. The presence of the at-risk C allele within the ALDH1A2 gene was maintained after fibroblast reprogramming. The iPSC lines obtained will enable us to model hand OA in vitro and to deeper study the role of this genetic variant in the pathogenesis of hand OA.


Disclosure: R. Castro-Viñuelas, None; C. Sanjurjo-Rodríguez, None; M. Piñeiro-Ramil, None; T. Hermida-Gómez, None; F. J. De Toro Santos, None; F. J. Blanco, None; I. Fuentes-Boquete, None; S. M. Díaz-Prado, None.

To cite this abstract in AMA style:

Castro-Viñuelas R, Sanjurjo-Rodríguez C, Piñeiro-Ramil M, Hermida-Gómez T, De Toro Santos FJ, Blanco FJ, Fuentes-Boquete I, Díaz-Prado SM. Generation of Human Induced Pluripotent Stem Cell Lines from Patients with Hand Osteoarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/generation-of-human-induced-pluripotent-stem-cell-lines-from-patients-with-hand-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/generation-of-human-induced-pluripotent-stem-cell-lines-from-patients-with-hand-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology